Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.

The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Abstract Text:

    eva hernandoEva Hernando,elizabeth charytonowiczElizabeth Charytonowicz,maria e dudasMaria E Dudas,silvia menendezSilvia Menendez,igor matushanskyIgor Matushansky,joslyn millsJoslyn Mills,nicholas d socciNicholas D Socci,nille behrendtNille Behrendt,li maLi Ma,robert g makiRobert G Maki,pier paolo pandolfiPier Paolo Pandolfi,carlos cordon-cardoCarlos Cordon-Cardo,

    We analyzed the PI3K-AKT signaling cascade in a cohort of sarcomas and found a marked induction of insulin receptor substrate-2 (IRS2) and phosphorylated AKT and a concomitant upregulation of downstream effectors in most leiomyosarcomas. To determine the role of aberrant PI3K-AKT signaling in leiomyosarcoma pathogenesis, we genetically inactivated Pten in the smooth muscle cell lineage by cross-breeding Pten(loxP/loxP) mice with Tagln-cre mice. Mice carrying homozygous deletion of Pten alleles developed widespread smooth muscle cell hyperplasia and abdominal leiomyosarcomas, with a very rapid onset and elevated incidence (approximately 80%) compared to other animal models. Constitutive mTOR activation was restricted to the leiomyosarcomas, revealing the requirement for additional molecular events besides Pten loss. The rapamycin derivative everolimus substantially decelerated tumor growth on Tagln-cre/Pten(loxP/loxP) mice and prolonged their lifespan. Our data show a new and critical role for the AKT-mTOR pathway in smooth muscle transformation and leiomyosarcoma genesis, and support treatment of selected sarcomas by the targeting of this pathway with new compounds or combinations of these with conventional chemotherapy agents.

    The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Publishing Authors By Initials

    e hernandoE Hernando,e charytonowiczE Charytonowicz,me dudasME Dudas,s menendezS Menendez,i matushanskyI Matushansky,j millsJ Mills,nd socciND Socci,n behrendtN Behrendt,l maL Ma,rg makiRG Maki,pp pandolfiPP Pandolfi,c cordon-cardoC Cordon-Cardo,

    For similar biological phenomena, cell phenomena, and immunity: cell physiology: cell communication: signal transduction research abstracts see: biological phenomena, cell phenomena, and immunity: cell physiology: cell communication: signal transduction research

    PUBMED ID PMID:

    MEDLINE DATE:

    The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Nature medicine

    VOLUME: 13

    Page Numbers: 748-53

    Journal Abbreviation: Nat. Med.

    ISSN: 1078-8956

    DAY: 13

    MONTH: 05

    YEAR: 2007

    The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9502015

    The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Keywords Mesh Terms:

    KEYWORDS: Signal Transduction

    MESH TERMS: physiology

    Chemical & Substance for Abstract: The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Information

    Substance Name: PTEN Phosphohydrolase

    Registry Number: EC 3.1.3.67

    Grant and Affiliation Information for The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.

    AFFILIATION: Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: P01 CA47179

    ACRONYM: CA

    MEDLINETA: Nat Med

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News